Patient Information Leaflet
Atorvastatina SUN 20 mg Film-Coated Tablets
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
- Keep this leaflet, as you may need to read it again.
- If you have any questions, ask your doctor, pharmacist or nurse.
- This medicine has been prescribed for you only. Do not give it to others even if they have the same symptoms as you, as it may harm them.
- If you experience any side effects, consult your doctor, pharmacist or nurse, even if they are not listed in this leaflet. See section 4.
1. What is Atorvastatina SUN and what is it used for
2. What you need to know before taking Atorvastatina SUN
3. How to take Atorvastatina SUN
4. Possible side effects
5. Storage of Atorvastatina SUN
6. Contents of the pack and additional information
Atorvastatina SUN belongs to a group of medicines known as statins, which are medicines that regulate lipids (fats).
Atorvastatina SUN is used to reduce lipids such as cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes on their own have failed. If you present a high risk of heart disease, Atorvastatina SUN may also be used to reduce this risk even if your cholesterol levels are normal. During treatment, a standard low-cholesterol diet must be followed.
Do not take Atorvastatina SUN
- if you are allergic to atorvastatina or any of the other ingredients of this medicine (listed in section 6).
- if you have or have had any liver disease
- if you have or have had abnormal results in liver function blood tests
- if you are a fertile woman and do not use adequate contraceptive measures
- if you are pregnant or trying to become pregnant
- if you are breastfeeding
- if you are taking the combination of glecaprevir/pibrentasvir for the treatment of hepatitis C
Warnings and precautions
Consult your doctor, pharmacist or nurse before starting to take Atorvastatina SUN.
In any of these cases, your doctor may instruct you to have blood tests before and possibly during treatment withAtorvastatina SUNto predict the risk of suffering adverse effects related to muscle. It is known that the risk of suffering adverse effects related to muscle (for example rhabdomyolysis) increases when certain medicines are taken at the same time (see section 2 "Use of Atorvastatina SUN with other medicines").
Also inform your doctor or pharmacist if you experience persistent muscle weakness. Further tests and additional medicines may be necessary to diagnose and treat this problem.
While you are taking this medicine, your doctor will monitor you for the development of diabetes or for being at risk of developing diabetes. You may be at risk of developing diabetes if you have high blood sugar and fat levels, are overweight and have high blood pressure.
Use of Atorvastatina SUN with other medicines
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medicine. There are some medicines that may affect the proper functioning ofAtorvastatina SUNor the effects of these medicines may be modified byAtorvastatina SUN. This type of interaction may reduce the effect of one or both medicines. Alternatively, this combined use may increase the risk or severity of adverse effects, including the important muscle deterioration, known as rhabdomyolysis described in section 4.
Possible adverse effects:
- Medicines used to modify the functioning of your immune system, for example ciclosporina.
TakingAtorvastatina SUNwith food and drinks
See section 3 for instructions on how to takeAtorvastatina SUN.
Please note the following:
Orange juice
Do not take more than one or two small glasses of orange juice per day because large amounts of orange juice may alter the effects ofAtorvastatina SUN.
Alcohol
Avoid drinking large amounts of alcohol while taking this medicine. See section 2 "Warnings and precautions".
Pregnancy and breastfeeding
Do not takeAtorvastatina SUNif you are pregnant or trying to become pregnant.
Do not takeAtorvastatina SUNif you are fertile and do not use adequate contraceptive measures.
Do not takeAtorvastatina SUNif you are breastfeeding your child.
The safety ofAtorvastatina SUNhas not been demonstrated during pregnancy and lactation.
Consult your doctor or pharmacist before using any medicine.
Driving and operating machines
Normally this medicine does not affect your ability to drive or operate machines. However, do not drive if this medicine affects your ability to drive. Do not handle tools or machines if this medicine affects your ability to handle them.
Atorvastatina SUN contains lactose
This medicine contains lactose. If your doctor has told you that you have a lactose intolerance, consult with him before taking this medicine.
This medicine contains less than 23 mg (1 mmol of sodium) per tablet, so it is considered essentially "sodium-free".
Before starting treatment, your doctor will put you on a low-cholesterol diet, which you must also follow during treatment with Atorvastatina SUN.
The usual initial dose of Atorvastatina SUN is 10 mg once a day in adults and children aged 10 years and older. Your doctor may increase it if necessary to reach the dose you need. Your doctor will adjust the dose at intervals of 4 weeks or more.
The maximum dose of Atorvastatina SUN is 80 mg once a day.
Atorvastatina SUN tablets should be swallowed whole with a glass of water and can be taken at any time of the day with or without food. However, try to take your tablet every day at the same time.
Follow exactly the administration instructions for this medication indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
Your doctor will decide the duration of treatment with Atorvastatina SUN.
Ask your doctor if you think the effect of Atorvastatina SUN is too strong or too weak.
If you take more Atorvastatina SUN than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forgot to take Atorvastatina SUN
If you forgot to take a dose, take the next scheduled dose at the correct time. Do not take a double dose to make up for the missed doses.
If you interrupt treatment with Atorvastatina SUN
If you have any other questions about the use of this medication or want to interrupt treatment, ask your doctor or pharmacist.
Like all medicines, Atorvastatina SUN can cause side effects, although not everyone will experience them.
If you experience any of the following serious side effects, stop taking these tablets and inform your doctor immediately or visit the nearest hospital emergency department.
Rare: may affect up to 1 in 1,000 people
- Severe allergic reaction that causes swelling of the face, tongue, and throat, which may make breathing difficult.
- Severe skin disease with severe peeling and inflammation; blisters on the skin, mouth, genitals, and eyes, and fever. Skin rash with pink-red spots, especially on the palms of the hands or soles of the feet that may form blisters.
- Muscle weakness, pain on palpation or rupture, and especially if you have discomfort or high fever, it may be due to an abnormal muscle rupture (rhabdomyolysis). This abnormal muscle rupture is not always reversible and may continue even after stopping Atorvastatina. It may be fatal and cause kidney problems.
Very rare: may affect up to 1 in 10,000 people
- Systemic lupus-like syndrome (including rash, joint disorders, and effects on blood cells).
Other possible side effects with Atorvastatina SUN
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
?allergic reaction - symptoms may include sudden hissing while breathing and chest pain or tightness, swelling of the eyelids, face, lips, mouth, tongue, or throat, difficulty breathing, collapse
Frequency not known: cannot be estimated from available data
Possible side effects of some statins (medicines of the same type):
?sexual difficulties
?depression
?respiratory problems such as persistent cough and/or difficulty breathing or fever
?diabetes. It is more likely if you have high blood sugar and fat levels, are overweight, or have high blood pressure. Your doctor will monitor you while you are taking this medication.
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not store this medication at a temperature above 25°C.
Do not use Atorvastatina SUN after the expiration date {CAD} that appears on the blister pack and on the packaging. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of AtorvastatinSUN
- The active ingredient is atorvastatin, as atorvastatina calcium trihydrate. Each film-coated tablet contains 20 mg of atorvastatin.
The other components (excipients) are:
Core of the tablets: microcrystalline cellulose (E460), lactose monohydrate, anhydrous colloidal silica, sodium croscarmellose (E468), sodium hydrogen carbonate, anhydrous sodium carbonate, hydroxypropyl cellulose (E463), magnesium stearate (E470b), butylhydroxyanisole, butylhydroxytoluene.
Coating: Opadry YS-1-7040 white (hypromellose (E464), macrogol 8000, titanium dioxide (E171) and talc (E553b)).
Appearance of the product and contents of the package
The tablets are white or off-white, oval, approximately 6.6 mm wide and 12.1 mm long, engraved with 'A31' on one face and smooth on the other face.
AtorvastatinaSUNis presented in packages of:
Cold-form blisters (polyamide/aluminum/PVC - united to an aluminum sheet coated with heat-sealed lacquer on its inner face.
The packages contain 10, 14, 20, 28, 30, 50, 56, 60, 84, 90, 98, 100 film-coated tablets.
Only some package sizes may be marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.
Polarisavenue, 87
2132 JH – Hoofddorp
Netherlands
Responsible for manufacturing:
TERAPIA S.A.
124 Fabricii Street
400 632 Cluj Napoca,
Romania
Or
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132JH- Hoofddorp
Netherlands
Local Representative:
Sun Pharma Laboratorios, S.L
Rambla de Catalunya, 53-55
08007 Barcelona
Spain
Tel: +34 93 342 78 90
This medicine is authorized in the following member states, with the following names:
BulgariaATORVISTAT K 20 mg?????????????????
FinlandAtorvastatinOrion20 mg tabletti, kalvopäällysteinen
FranceATORVASTATINE SUN 20 mg, comprimé pelliculé
IrelandAtorvastatin 20 mg film-coated tablets
LithuaniaAtorvastatin SUN 20 mg plevele dengtos tabletes
LatviaAtorvastatin SUN 20 mg apvalkotas tabletes
PolandStorvas CRT
RomaniaAtorvastatin Terapia 20 mg comprimate filmate
SpainAtorvastatinaSUN20 mg Comprimidos recubiertos conpelícula EFG
United KingdomAtorvastatin 20 mg Film-coated Tablets
Date of the last review of this leaflet: February 2022.
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.